read_file: Read file contents with flexible line range control edit_file: Make precise edits to files with clear instructions Supports complete file replacement ...

Omeros Corporation (OMER) announced on Wednesday that the U.S. FDA approved its lead asset, narsoplimab-wuug, as a treatment for hematopoietic stem cell transplant-associated thrombotic ...

MIAMI GARDENS — Miami Dolphins running back De’Von Achane earned his first Pro Bowl nod, the NFL announced Tuesday morning, but linebacker Jordyn Brooks and other deserving candidates were left off ...

Giants rookie Abdul Carter has a correction when it comes to Brian Burns' recent nod to the NFL Pro Bowl amidst a great season. The rookie defensive end took to X, formerly Twitter, and reposted the ...

The field for the 2026 Masters has reached 86 players with those finishing the 2025 calendar year inside the top 50 of the Official World Golf Rankings earning invitations into the first major ...

Photo Credit: Ritesh Agarwal, CEO and founder of Prism, spoke on-stage at Skift India Summit in Delhi-NCR in March 2024. Source: Skift. Skift The shareholders approval for Prism's IPO signals a ...

It always pays to be a first-round pick in any sport, but things can get lucrative when a second-round pick without a fifth-year option quickly develops into one of the best defenders on the planet.

Dec 23 (Reuters) - (This Dec. 23 story has been refiled to remove an image, with no changes to the text) India's Oyo Hotels' parent company Prism received shareholders' approval to raise up to 66.50 ...

Despite the Tennessee Titans taking quarterback Cam Ward with the No. 1 overall pick in last year’s draft, former Florida Gators wide receiver Chimere Dike has been their brightest rookie in 2025, as ...

Slated for a Dec. 26 decision on Cytokinetics’ aficamten, the FDA has delivered an early Christmas present, awarding the South San Francisco biotech its first U.S. nod since its 1997 founding. The ...

Just two months after reviving its prowess in the idiopathic pulmonary fibrosis (IPF) treatment area with rare lung disease med Jascayd, Boehringer Ingelheim is already unlocking another patient ...